Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

Merlin ends drought for Boston tech firms after listing this week on the Nasdaq exchange

Audit committee shortfall puts Lifeward (NASDAQ: LFWD) on Nasdaq non-compliance notice

Market risk a la 2022 (SP500:)

Russell 2000 enters correction territory, and the Dow, S&P 500, and Nasdaq are not far off

US stocks slide, Nasdaq, Dow near corrections amid Iran war